Less paper means more trees.� Live green.
EMR & Klara Texting

Medical records are�maintained and securely stored in a cloud-based system run by RxNT.� Records are always available and prescriptions can be sent electronically to any pharmacy in the United States.

RxNT

Dr. Schroeder uses Klara, a secure, HIPPA-certifed texting system to communicate simple messages and receive simple feedback from patients.� It can also be used to send digital medical records.

Screen_Shot_2018-06-30_at_8





Phone:� 310-734-4594
Address:� 9401 Wilshire Blvd, Ste 515, Beverly Hills, CA 90212


Actavis finasteride hair loss


Finasteride Hair Loss Baldness Tablets
4-5 stars based on 85 reviews

Finasteride and women's hair loss ) and, for the first time, a single drug was able to increase male fertility in humans. It is called a "male contraceptive" but, for obvious reasons, it is currently only being used on animals. But now the first human trial is under way in Spain. The drug, first ever used to boost fertility in men, was tested 17 men without any sexual experience to ensure no side effects. Advertisement The men were given drug every other day for a period of 28 days. If success is confirmed, the drug has potential to offer a new option help couples wanting to have children. The first of three trials took place at the Instituto del General de Investigaciones Cientificas (IGIC) in Madrid. The men all had experienced a total of 20 failed attempts at conceiving and were taking an average of eight different medications to try boost the chance of success. In one of the trials, men were given a dose of hormone known as androstenedione. It's a precursor to testosterone. The men received injections of 25 micrograms androstenedione, which can also trigger sperm production. The second trial used a combination of two anti-estrogen drugs known as raloxifene and ethinyl estradiol to boost sperm production. This drug combination was injected every other day for a total of six weeks. The third finasteride for women's hair loss trial, taking place at the University Hospital of Madrid (Hospital Carlos III) is the first study to use male contraceptive drug that has passed its safety trial and has now been submitted to the European Medicines Agency (EMA) for approval. The results of these human trials are hoped to reveal if the drug can increase number of sperm in men by increasing the number of healthy male sperm. If this proves to be the cas